Furthermore, as the risk factors of TLF in this cohort, insulin‐treated diabetes, hemodialysis, peripheral vascular disease, and in‐stent restenosis were those of clinically indicated TLR (Tables 4 and 5). The gene discussed is INS; the disease is peripheral vascular disease.